These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35691018)

  • 1. Detection, identification, characterization, and high-performance liquid chromatography quantification of five impurities from a methazolamide product.
    Shen Q; He Q; Pan Y; Sun C
    J Sep Sci; 2022 Aug; 45(16):3128-3138. PubMed ID: 35691018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges.
    Patel DN; Li L; Kee CL; Ge X; Low MY; Koh HL
    J Pharm Biomed Anal; 2014 Jan; 87():176-90. PubMed ID: 23721687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of Impurity Profiling Methods Using Modern Analytical Techniques.
    Ramachandra B
    Crit Rev Anal Chem; 2017 Jan; 47(1):24-36. PubMed ID: 27070830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of impurities in the repurposed COVID-19 drug hydroxychloroquine sulfate using ultra-high-performance liquid chromatography-quadrupole/time-of-flight mass spectrometry and liquid chromatography-solid-phase extraction-nuclear magnetic resonance.
    Xu D; Pan F; Ruan H; Sun N
    Rapid Commun Mass Spectrom; 2022 Oct; 36(20):e9358. PubMed ID: 35880971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of new trace related impurities in adenosine products using ultra-high-performance liquid chromatography/electrospray ionization quadrupole time-of-flight tandem mass spectrometry.
    Shen Y; Zhai P; Xi P; Chen C; Mou F; Li F; Zhang J
    Rapid Commun Mass Spectrom; 2019 Nov; 33(22):1739-1750. PubMed ID: 31146299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical practical aspects in the application of liquid chromatography-mass spectrometric studies for the characterization of impurities and degradation products.
    Narayanam M; Handa T; Sharma P; Jhajra S; Muthe PK; Dappili PK; Shah RP; Singh S
    J Pharm Biomed Anal; 2014 Jan; 87():191-217. PubMed ID: 23706957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of unknown impurities in Coenzyme Q
    Deng Y; Chen X; Wang L; Peng X; Lin M
    J Pharm Biomed Anal; 2019 Oct; 175():112771. PubMed ID: 31330281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of four process-related impurities in retigabine.
    Wang X; Zhou H; Zheng J; Huang C; Liu W; Yu L; Zeng S
    J Pharm Biomed Anal; 2012 Dec; 71():148-51. PubMed ID: 22954446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and identification of process impurities in trimethoprim drug substance by high-performance liquid chromatography, atmospheric pressure chemical ionization liquid chromatography/mass spectrometry and nuclear magnetic resonance spectroscopy.
    Lehr GJ; Barry TL; Petzinger G; Hanna GM; Zito SW
    J Pharm Biomed Anal; 1999 Mar; 19(3-4):373-89. PubMed ID: 10704103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impurity profile and spectrum characteristics of the isomers in cefamandole nafate using high- performance liquid chromatography/high-performance size exclusion chromatography tandem ion trap/time-of-flight mass spectrometry.
    Wang F; Gao J; Chen H; Zhu B; Li P; Wang J; Hong L
    Rapid Commun Mass Spectrom; 2022 Dec; 36(23):e9399. PubMed ID: 36114650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification, isolation and characterization of impurities of clindamycin palmitate hydrochloride.
    Bharathi Ch; Jayaram P; Sunder Raj J; Saravana Kumar M; Bhargavi V; Handa VK; Dandala R; Naidu A
    J Pharm Biomed Anal; 2008 Dec; 48(4):1211-8. PubMed ID: 18947955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural studies of racecadotril and its process impurities by NMR and mass spectroscopy.
    Reddy KM; Babu JM; Sudhakar P; Sharma MS; Reddy GS; Vyas K
    Pharmazie; 2006 Dec; 61(12):994-8. PubMed ID: 17283655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of impurities in methotrexate drug substances using high-performance liquid chromatography coupled with a photodiode array detector and Fourier transform ion cyclotron resonance mass spectrometry.
    Wu CS; Tong YF; Wang PY; Wang DM; Wu S; Zhang JL
    Rapid Commun Mass Spectrom; 2013 May; 27(9):971-8. PubMed ID: 23592199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification, characterization, and high-performance liquid chromatography quantification of process-related impurities in vonoprazan fumarate.
    Liu L; Cao N; Ma X; Xiong K; Sun L; Zou Q
    J Sep Sci; 2016 Apr; 39(7):1232-41. PubMed ID: 26843471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of some potential impurities in ropinirole hydrochloride.
    Sahasrabuddhey B; Nautiyal R; Acharya H; Khyade S; Luthra PK; Deshpande PB
    J Pharm Biomed Anal; 2007 Mar; 43(4):1587-93. PubMed ID: 17207602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levothyroxine sodium revisited: A wholistic structural elucidation approach of new impurities via HPLC-HRMS/MS, on-line H/D exchange, NMR spectroscopy and chemical synthesis.
    Ruggenthaler M; Grass J; Schuh W; Huber CG; Reischl RJ
    J Pharm Biomed Anal; 2017 Feb; 135():140-152. PubMed ID: 28024262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly efficient, selective, sensitive and stability indicating RP-HPLC-UV method for the quantitative determination of potential impurities and characterization of four novel impurities in eslicarbazepine acetate active pharmaceutical ingredient by LC/ESI-IT/MS/MS.
    Thomas S; Bharti A; Maddhesia PK; Shandilya S; Agarwal A; Dharamvir ; Biswas S; Bhansal V; Gupta AK; Tewari PK; Mathela CS
    J Pharm Biomed Anal; 2012 Mar; 61():165-75. PubMed ID: 22178334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Separation and characterization of impurity P in azithromycin product.
    Guo N; He Q; Jin Y; Hou Z; Pan Y; Liu J; Sun C
    J Pharm Biomed Anal; 2021 Feb; 195():113853. PubMed ID: 33358623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the impurities and isomers in cefetamet pivoxil hydrochloride by liquid chromatography/time-of-flight mass spectrometry and ion trap mass spectrometry.
    Wang D; Wang F; Wang J
    J Pharm Biomed Anal; 2015; 111():71-7. PubMed ID: 25863019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.